MedPath

An observational study to investigate utility and issue of a platform that performs the online examination with monitoring using digital devices, online instruction on the use of drugs and delivering drugs for patients with Parkinson's disease

Not Applicable
Completed
Conditions
Parkinson's disease
Registration Number
JPRN-jRCT1080225200
Lead Sponsor
Takeda Pharmaceutical Company Limited
Brief Summary

The results of questionnaires showed that patients, caregivers, physicians, and pharmacists were somewhat satisfied, indicating that this solution is acceptable to a certain extent. The result of this study should contribute to the future development and dissemination of this and similar online platforms.

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1. The participant is capable of operating each device used in this study, and understanding and complying with protocol requirements, in the opinion of the investigator.
2. The participant signs and dates a written, informed consent form prior to the initiation of any study procedures.
3. The participant has been diagnosed with Parkinson's disease on the basis of standardized diagnostic criteria.
4. The participant has some difficulty in visiting the outpatient clinic, and it is preferable to conduct online examination, online instruction on the use of drugs, and delivering drugs as part of regular care, in the opinion of the investigator.
5. The participant is a resident of Kanagawa Prefecture.
6. The participant is aged 20 years or older at the time of informed consent.
7. The participant is capable of visiting the outpatient clinic during the evaluation period.

Exclusion Criteria

1. The participant has metal allergy.
2. The participant has cognitive impairment that, in the opinion of the investigator, would interfere with the ability to report on symptoms and function.
3. The participant has unstable Parkinson's disease and co-morbidities.
4. The participant is judged by the investigator as being ineligible for any other reason.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
other<br>Patient satisfaction with examination and instruction on the use of drugs (Client Satisfaction Questionnaire 8 [CSQ-8])<br>Time Frame: Week 0, 4 and 16
Secondary Outcome Measures
NameTimeMethod
other<br>Satisfactions and issues with the platform (using questionnaire filled by patients, caregivers, physicians, medical office work divisions of the medical institutions, and pharmacists)<br>Time Frame: Week 16
© Copyright 2025. All Rights Reserved by MedPath